-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$55.0068.35% Upside
Celldex Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. has been rated by research analysts at Wells Fargo, Stifel Nicolaus, Guggenheim in the past 90 days.